| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Altamira Therapeutics (NASDAQ:CYTO) reported quarterly losses of $(16.47) per share. This is a 97.38 percent increase over loss...
Companies Reporting Before The Bell • Delta Air Lines (NYSE:DAL) is projected to report quarterly earnings at $0.35 per share ...
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0....
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow trad...
Altamira Therapeutics shares are trading higher Monday after the company announced that it has entered into a collaboration agr...
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 50 points on Monday. Following the market op...
